These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 24961113)

  • 1. [Synergetic taste masking of lipid coating and beta-cyclodextrin inclusion].
    Li X; Guo Z; Hao JB; Li B; Liu CB; Guo T; Li HY; Shi SL; Wang LY; Zhang JW
    Yao Xue Xue Bao; 2014 Mar; 49(3):392-8. PubMed ID: 24961113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host-guest kinetic interactions between HP-β-cyclodextrin and drugs for prediction of bitter taste masking.
    Guo Z; Wu F; Singh V; Guo T; Ren X; Yin X; Shao Q; York P; Patterson LH; Zhang J
    J Pharm Biomed Anal; 2017 Jun; 140():232-238. PubMed ID: 28365517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microstructural investigation using synchrotron radiation X-ray microtomography reveals taste-masking mechanism of acetaminophen microspheres.
    Guo Z; Yin X; Liu C; Wu L; Zhu W; Shao Q; York P; Patterson L; Zhang J
    Int J Pharm; 2016 Feb; 499(1-2):47-57. PubMed ID: 26712269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Masking the bitter taste of injectable lidocaine HCl formulation for dental procedures.
    Wei Y; Nedley MP; Bhaduri SB; Bredzinski X; Boddu SH
    AAPS PharmSciTech; 2015 Apr; 16(2):455-65. PubMed ID: 25361901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inclusion of Paracetamol into β-cyclodextrin nanocavities in solution and in the solid state.
    El-Kemary M; Sobhy S; El-Daly S; Abdel-Shafi A
    Spectrochim Acta A Mol Biomol Spectrosc; 2011 Sep; 79(5):1904-8. PubMed ID: 21703916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantifying the bitter masking effect of drug-cyclodextrin complexation: NMR-ROESY mixing time approach.
    Ueda T; Yamaguchi MS; Christian-Tabak L; Takai Y; Tode C
    Carbohydr Res; 2024 Mar; 537():109067. PubMed ID: 38442683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computer-assisted design for paracetamol masking bitter taste prodrugs.
    Hejaz H; Karaman R; Khamis M
    J Mol Model; 2012 Jan; 18(1):103-14. PubMed ID: 21491187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative in vitro and in vivo taste assessment of liquid praziquantel formulations.
    Münster M; Mohamed-Ahmed AHA; Immohr LI; Schoch C; Schmidt C; Tuleu C; Breitkreutz J
    Int J Pharm; 2017 Aug; 529(1-2):310-318. PubMed ID: 28689966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of the inclusion complexes formed between cetirizine and α-, β-, and γ-cyclodextrin and evaluation on their taste-masking properties.
    Stojanov M; Wimmer R; Larsen KL
    J Pharm Sci; 2011 Aug; 100(8):3177-3185. PubMed ID: 21394723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM; Elkheshen SA; Ghorab MM
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of nano zinc oxide and nano chitosan on the taste masking paracetamol granules.
    Rashidi T; Shakeri A
    Drug Dev Ind Pharm; 2024 Jun; 50(6):495-510. PubMed ID: 38718260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel oral delivery system consisting in "drug-in cyclodextrin-in nanostructured lipid carriers" for poorly water-soluble drug: vinpocetine.
    Lin C; Chen F; Ye T; Zhang L; Zhang W; Liu D; Xiong W; Yang X; Pan W
    Int J Pharm; 2014 Apr; 465(1-2):90-6. PubMed ID: 24530388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taste masking of water-soluble drug by solid lipid microspheres: a child-friendly system established by reversed lipid-based nanoparticle technique.
    Zhang Y; Shen L; Wang T; Li H; Huang R; Zhang Z; Wang Y; Quan D
    J Pharm Pharmacol; 2020 Jun; 72(6):776-786. PubMed ID: 32153037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular modeling and cytotoxicity of diffractaic acid: HP-β-CD inclusion complex encapsulated in microspheres.
    Silva CV; Barbosa JA; Ferraz MS; Silva NH; Honda NK; Rabello MM; Hernandes MZ; Bezerra BP; Cavalcanti IM; Ayala AP; Santos NP; Santos-Magalhães NS
    Int J Biol Macromol; 2016 Nov; 92():494-503. PubMed ID: 27451026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of coat uniformity and taste-masking efficiency of irregular-shaped drug particles coated in a modified tangential spray fluidized bed processor.
    Xu M; Heng PW; Liew CV
    Expert Opin Drug Deliv; 2015; 12(10):1597-606. PubMed ID: 26051826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro and in-vivo evaluation of taste-masked cetirizine hydrochloride formulated in oral lyophilisates.
    Preis M; Grother L; Axe P; Breitkreutz J
    Int J Pharm; 2015 Aug; 491(1-2):8-16. PubMed ID: 26051543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergetic skin targeting effect of hydroxypropyl-β-cyclodextrin combined with microemulsion for ketoconazole.
    Che J; Wu Z; Shao W; Guo P; Lin Y; Pan W; Zeng W; Zhang G; Wu C; Xu Y
    Eur J Pharm Biopharm; 2015 Jun; 93():136-48. PubMed ID: 25845772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of β-cyclodextrin inclusion complex and self-microemulsifying drug delivery system for photostability and enhanced oral bioavailability of methotrexate: novel technique.
    Bourkaib N; Zhou J; Yao J; Fang Z; Mezghrani O
    Drug Dev Ind Pharm; 2013 Jun; 39(6):918-27. PubMed ID: 22998295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and evaluation of meloxicam oral disintegrating tablet with dissolution enhanced by combination of cyclodextrin and ion exchange resins.
    Samprasit W; Akkaramongkolporn P; Ngawhirunpat T; Rojanarata T; Opanasopit P
    Drug Dev Ind Pharm; 2015 Jun; 41(6):1006-16. PubMed ID: 24865111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of the aqueous solubility and masking the bitter taste of famotidine using drug/SBE-beta-CyD/povidone K30 complexation approach.
    Mady FM; Abou-Taleb AE; Khaled KA; Yamasaki K; Iohara D; Ishiguro T; Hirayama F; Uekama K; Otagiri M
    J Pharm Sci; 2010 Oct; 99(10):4285-94. PubMed ID: 20737636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.